| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.006 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.15 | 0.006 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.091 | 0.006 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.006 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.14 | 0.007 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.008 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.095 | 0.008 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.086 | 0.009 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.01 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.01 |